Success Metrics

Clinical Success Rate

100.0%

Based on 3 completed trials

Completion Rate

100%(3/3)

Active Trials

0(0%)

Results Posted

33%(1 trials)

Phase Distribution

Ph phase_1

20%

Ph phase_3

20%

Ph not_applicable

40%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

Phase 1Safety & dosage

1(25.0%)

Phase 3Large-scale testing

1(25.0%)

N/ANon-phased studies

2(50.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(3)

Other(1)

Detailed Status

Completed3

Enrolling by invitation1

unknown1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 3

Trials by Phase

Phase 11 (25.0%)

Phase 31 (25.0%)

N/A2 (50.0%)

Trials by Status

enrolling_by_invitation120%

unknown120%

completed360%

Recent Activity

0 active trials

Showing 5 of 5

completed

Idiopathic Bilateral Vestibulopathy: Peripheral Vestibular Disorders and Their Repercussions

NCT06476587

enrolling_by_invitationnot_applicable

The Role of Advanced Electroencephalographic Data as Marker of Pathology and Prognosis in Primary Dementias

NCT06826157

completednot_applicable

Clinical Trials (5)

Showing 5 of 5 trials

NCT06476587

Idiopathic Bilateral Vestibulopathy: Peripheral Vestibular Disorders and Their Repercussions

Completed

NCT06826157Not Applicable

The Role of Advanced Electroencephalographic Data as Marker of Pathology and Prognosis in Primary Dementias

Enrolling By Invitation

NCT04089332Not Applicable

Insulin Resistance in Adolescents

Completed

NCT02936687Phase 1

Mechanisms of Cerebrovascular Control

Completed

NCT02751606Phase 3

Nano MRI on 7 Tesla in Rectal and Breast Cancer

Unknown

All 5 trials loaded

Drug Details

Intervention Type: DIAGNOSTIC TEST
Total Trials: 5